| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |